한글목차

계산생물학 동향과 예측

세계 계산생물학 시장은 2024년부터 2030년까지 13.4%의 연평균 성장률(CAGR)을 기록하며 2030년까지 약 128억 달러에 달할 것으로 예상됩니다. 이 시장의 주요 촉진요인은 신약 개발에서 AI 기반 기술 활용의 확대와 약물 설계 및 질병 모델링에 대한 관심의 증가입니다. 세계 계산생물학 시장의 미래는 학술 및 연구 분야와 상업적 분야에서 기회가 많아 유망한 시장으로 평가됩니다.

계산생물학 시장 인사이트

Lucintel은 예측 기간 동안 세포 및 생물학 시뮬레이션이 가장 높은 성장세를 보일 것으로 예상하고 있습니다.

이 시장에서는 유전공학 및 신약개발 연구개발에 대한 공공 및 민간 부문의 지출이 증가함에 따라 예측 기간 동안 상업 부문이 더 높은 성장세를 보일 것으로 예상됩니다.

북미 지역은 탄탄한 의료 인프라, 만성 질환 환자 증가, 주요 기업의 존재로 인해 가장 큰 지역으로 남아 있습니다.

이 보고서는 다음과 같은 11가지 주요 질문에 대한 답변을 담고 있습니다:

• Q.1. 시장 부문 중 가장 유망하고 성장성이 높은 기회는 무엇인가?
• Q.2. 어떤 부문이 더 빠른 속도로 성장할 것이며, 그 이유는 무엇인가?
• Q.3. 향후 성장이 가속화될 것으로 예상되는 지역과 그 이유는?
• Q.4. 시장 역학에 영향을 미치는 주요 요인은 무엇인가? 시장의 주요 과제와 비지니스 리스크는 무엇인가?
• Q.5. 이 시장에서의 비지니스 리스크와 경쟁 위협은 무엇인가?
• Q.6. 이 시장의 새로운 트렌드와 그 이유는?
• Q.7. 시장에서의 고객 수요 변화에는 어떤 것들이 있는가?
• Q.8. 이 시장의 새로운 발전과 그 발전을 주도하고 있는 기업은?
• Q.9. 이 시장의 주요 기업은? 주요 기업들은 사업 성장을 위해 어떤 전략적 노력을 기울이고 있는가?
• Q.10. 이 시장의 경쟁 제품에는 어떤 것들이 있으며, 소재 및 제품 대체에 따른 시장 점유율 하락의 위협은 어느 정도인가?
• Q.11. 지난 5년간 어떤 M&A가 이루어졌고, 업계에 어떤 영향을 미쳤는가?

목차

제1장 주요 요약

제2장 세계의 계산생물학 시장 : 시장 역학

• 서론, 배경, 분류
• 공급망
• 업계 성장 촉진요인과 과제

제3장 2018년부터 2030년까지 시장 동향과 예측 분석

• 거시경제 동향(2018-2023년)과 예측(2024-2030년)
• 세계의 계산생물학 시장 동향(2018-2023)과 예측(2024-2030)
• 서비스별 세계 계산생물학 시장
  • 계약
  • 사내
• 용도별 세계 계산생물학 시장
  • 세포 및 생물학적 시뮬레이션
  • Drug Discovery와 질환 모델링
  • 전임상 약의 개발
  • 임상시험
  • 인체 시뮬레이션 소프트웨어
  • 기타
• 최종 이용 산업별 세계 계산생물학 시장
  • 학술과 연구
  • 상업
  • 기타

제4장 2018년부터 2030년까지 지역별 시장 동향과 예측 분석

• 지역별 세계의 계산생물학 시장
• 북미의 계산생물학 시장
• 유럽의 계산생물학 시장
• 아시아태평양 계산생물학 시장
• 기타 지역 계산생물학 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영상 통합
• Porter's Five Forces 분석

제6장 성장 기회와 전략적 분석

• 성장 기회 분석
  • 서비스별 세계 계산생물학 시장 성장 기회
  • 용도별 세계 계산생물학 시장 성장 기회
  • 최종 이용 산업별 세계 계산생물학 시장 성장 기회
  • 지역별 세계의 계산생물학 시장 성장 기회
• 세계의 계산생물학 시장의 최신 동향
• 전략적 분석
  • 신제품의 개발
  • 세계의 계산생물학 시장 능력 확대
  • 세계의 계산생물학 시장 합병, 인수, 합작투자
  • 인증과 라이선싱

제7장 유력 기업의 기업 개요

• Genedata
• Rhenovia Pharma
• Compugen
• Chemical Computing
• Certara
• Nimbus Discovery
• Rhenovia Pharma & Leadscope
• Simulation Plus
• Entelos
• Insilico Biotechnology

영문목차

Computational Biology Trends and Forecast

The future of the global computational biology market looks promising with opportunities in the academic & research and commercial sectors. The global computational biology market is expected to reach an estimated $12.8 billion by 2030 with a CAGR of 13.4% from 2024 to 2030. The major drivers for this market are expanding use of AI-based technology in drug discovery and growing interest in drug design and disease modeling.

A more than 150-page report is developed to help in your business decisions.

Computational Biology by Segment

The study includes a forecast for the global computational biology by service, application, end use industry, and region.

Computational Biology Market by Service [Shipment Analysis by Value from 2018 to 2030]:

• Contract
• In-House

Computational Biology Market by Application [Shipment Analysis by Value from 2018 to 2030]:

• Cellular & Biological Simulation
• Drug Discovery & Disease Modelling
• Preclinical Drug Development
• Clinical Trials
• Human Body Simulation Software
• Others

Computational Biology Market by End Use Industry [Shipment Analysis by Value from 2018 to 2030]:

• Academics & Research
• Commercial
• Others

Computational Biology Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Computational Biology Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies computational biology companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the computational biology companies profiled in this report include-

• Genedata
• Rhenovia Pharma
• Compugen
• Chemical Computing
• Certara
• Nimbus Discovery
• Rhenovia Pharma & Leadscope
• Simulation Plus
• Entelos
• Insilico Biotechnology

Computational Biology Market Insights

Lucintel forecasts that cellular & biological simulation is expected to witness highest growth over the forecast period.

Within this market, commercial is expected to witness higher growth over the forecast period due to increasing public and private sector spending on research and development in genetic engineering and the development of new drugs.

North America will remain the largest region due to existence of robust healthcare infrastructure, growing cases of chronic disease, and presence of key players in the region.

Features of the Global Computational Biology Market

Market Size Estimates: Computational biology market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Computational biology market size by service, application, end use industry, and region in terms of value ($B).

Regional Analysis: Computational biology market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different services, applications, end use industries, and regions for the computational biology market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the computational biology market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the computational biology market size?

Answer: The global computational biology market is expected to reach an estimated $12.8 billion by 2030.

Q.2 What is the growth forecast for computational biology market?

Answer: The global computational biology market is expected to grow with a CAGR of 13.4% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the computational biology market?

Answer: The major drivers for this market are expanding use of AI-based technology in drug discovery and growing interest in drug design and disease modeling.

Q4. What are the major segments for computational biology market?

Answer: The future of the computational biology market looks promising with opportunities in the academic & research and commercial sectors.

Q5. Who are the key computational biology market companies?

Answer: Some of the key computational biology companies are as follows:

• Genedata
• Rhenovia Pharma
• Compugen
• Chemical Computing
• Certara
• Nimbus Discovery
• Rhenovia Pharma & Leadscope
• Simulation Plus
• Entelos
• Insilico Biotechnology

Q6. Which computational biology market segment will be the largest in future?

Answer: Lucintel forecasts that cellular & biological simulation is expected to witness highest growth over the forecast period.

Q7. In computational biology market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to existence of robust healthcare infrastructure, growing cases of chronic disease, and presence of key players in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the computational biology market by service (contract and in-house), application (cellular & biological simulation, drug discovery & disease modelling, preclinical drug development, clinical trials, human body simulation software, and others), end use industry (academics & research, commercial, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Computational Biology Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Computational Biology Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Computational Biology Market by Service
  • 3.3.1: Contract
  • 3.3.2: In-house
• 3.4: Global Computational Biology Market by Application
  • 3.4.1: Cellular & Biological Simulation
  • 3.4.2: Drug Discovery & Disease Modelling
  • 3.4.3: Preclinical Drug Development
  • 3.4.4: Clinical Trials
  • 3.4.5: Human Body Simulation Software
  • 3.4.6: Others
• 3.5: Global Computational Biology Market by End Use Industry
  • 3.5.1: Academics & Research
  • 3.5.2: Commercial
  • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Computational Biology Market by Region
• 4.2: North American Computational Biology Market
  • 4.2.1: North American Computational Biology Market by Application: Cellular & Biological Simulation, Drug Discovery & Disease Modelling, Preclinical Drug Development, Clinical Trials, Human Body Simulation Software, and Others
  • 4.2.2: North American Computational Biology Market by End Use Industry: Academics & Research, Commercial, and Others
• 4.3: European Computational Biology Market
  • 4.3.1: European Computational Biology Market by Application: Cellular & Biological Simulation, Drug Discovery & Disease Modelling, Preclinical Drug Development, Clinical Trials, Human Body Simulation Software, and Others
  • 4.3.2: European Computational Biology Market by End Use Industry: Academics & Research, Commercial, and Others
• 4.4: APAC Computational Biology Market
  • 4.4.1: APAC Computational Biology Market by Application: Cellular & Biological Simulation, Drug Discovery & Disease Modelling, Preclinical Drug Development, Clinical Trials, Human Body Simulation Software, and Others
  • 4.4.2: APAC Computational Biology Market by End Use Industry: Academics & Research, Commercial, and Others
• 4.5: ROW Computational Biology Market
  • 4.5.1: ROW Computational Biology Market by Application: Cellular & Biological Simulation, Drug Discovery & Disease Modelling, Preclinical Drug Development, Clinical Trials, Human Body Simulation Software, and Others
  • 4.5.2: ROW Computational Biology Market by End Use Industry: Academics & Research, Commercial, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Computational Biology Market by Service
  • 6.1.2: Growth Opportunities for the Global Computational Biology Market by Application
  • 6.1.3: Growth Opportunities for the Global Computational Biology Market by End Use Industry
  • 6.1.4: Growth Opportunities for the Global Computational Biology Market by Region
• 6.2: Emerging Trends in the Global Computational Biology Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Computational Biology Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Computational Biology Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Genedata
• 7.2: Rhenovia Pharma
• 7.3: Compugen
• 7.4: Chemical Computing
• 7.5: Certara
• 7.6: Nimbus Discovery
• 7.7: Rhenovia Pharma & Leadscope
• 7.8: Simulation Plus
• 7.9: Entelos
• 7.10: Insilico Biotechnology